| Melichar B, Hyspler R, Dragounová E, et al. Intestinal permeability and toxicity of second-line therapeutic agents in ovarian cancer. [Comment, Letter, Research Support, Non-U.S. Gov't] Tumori 2008 Jul-Aug; 94(4):624-6. Full Citation | | Corvò R [In Process Citation] [Journal Article] Tumori 2008 Jul-Aug; 94(4):suppl 30-3. Full Citation | | Benasso M [In Process Citation] [Journal Article] Tumori 2008 Jul-Aug; 94(4):suppl 26-9. Full Citation | | Benasso M, Corvò R [In Process Citation] [Journal Article] Tumori 2008 Jul-Aug; 94(4):suppl 24-5. Full Citation | | Longo F, Mansueto G [In Process Citation] [Journal Article] Tumori 2008 Jul-Aug; 94(4):suppl 15-23. Full Citation | | Mansueto G, Longo F [In Process Citation] [Journal Article] Tumori 2008 Jul-Aug; 94(4):suppl 1-14. Full Citation | | Zanon C Phase 0 trial as first human study in translational research in medical technology. [Letter] Tumori 2008 Jul-Aug; 94(4):626-7. Full Citation | Find Related Articles | | Ballardini P, Gamberini S, Margutti G, et al. Hepatic abscess and silent underlying colon cancer: an emerging association? [Comment, Letter] Tumori 2008 Jul-Aug; 94(4):624. Full Citation | | Tassinari D, Santelmo C, Tombesi P, et al. Clinical guidelines in advanced cancer: why we cannot avoid an evidence-based model. [Comment, Letter] Tumori 2008 Jul-Aug; 94(4):622-3. Full Citation | Find Related Articles | | De Padova S, Carlà G, Maniglia R, et al. Communication near the end of life. [Comment, Letter] Tumori 2008 Jul-Aug; 94(4):621; author reply 621-2. Full Citation | Find Related Articles |  |
|
| | Enter www.unboundmedicine.com/medline in your iPhone browser or View our Unbound MEDLINE iPhone demo Advertise on this site.
|